Abstract and Special Interest Groups (SIG) submission will be open Monday, October 16 - December 1, 2017
The Annual Meeting Program Committee (AMPC) seeks high-quality abstracts describing original, unpublished research results that contain a clear statement of hypothesis, an explanation of methods, a report of data that unequivocally test the hypothesis, and a brief discussion of the implications.
The abstract must be work that has not been submitted for publication or preprint before the abstract submission deadline. After the abstract submission deadline of December 1, 2017, an author is at liberty to submit their abstract to a journal or a preprint for publication consideration.
Start preparing now to present your work at this premier eye and vision research event.
- Abstract Submission Policies and Procedures
- Abstract Submission FAQs
- Abstract Submission Tutorial
- 2018 Reviewing Codes
- Successful Abstract Submission Guidelines
- SIG Submission and Submission Guidelines
- Commercial Relationship Disclosures
- Registering Clinical Trials
- Abstract Rejection Criteria
- Abstract Withdrawal and Substitute Presenter Policy
- ARVO Abstract Citation Statement
- The link to the abstract submission site is located at the bottom of the page.
Key dates for the 2018 Abstract Program
|Oct. 16, 2017||Abstract submission site opens|
|Dec. 1, 2017||Abstract submission deadline|
|Dec. 5, 2017||Abstract complete notification will be sent to First Authors|
|Jan. 10, 2018||Abstract review notification will be sent to First Author|
|Jan. 29, 2018||Withdrawal deadline (BEFORE PUBLICATION)|
|Feb. 14, 2018||Abstract scheduling notification sent to First Authors|
Abstract Submission Policy
- The abstract must be work that has not been submitted for publication or preprint server before the abstract submission deadline. After the abstract submission deadline, and the author is at liberty to submit their abstract to a journal or a preprint server for publication consideration.
- Before submission, work in an abstract must be approved by the Principal Investigator (PI).
- An individual may be First (submitting) Author of only one abstract and must be the individual whose name appears first on the abstract.
- An abstract must be submitted with the intention that, if accepted, it will be presented by the First Author.
- There is no limit to the number of times an individual may appear as a co-author on multiple abstracts.
- Note: Multiple abstract submissions from the same institution on similar research will be subjected to rejection. See the 4.3 in the Abstract Rejection Criteria.
- Retired, Emeritus Fellows and Online-only members are not eligible to submit abstracts for ARVO Annual Meetings.
Commercial Relationship Disclosure Procedures
- All financial relationships with commercial interests relevant to the research reported in the abstract must be disclosed.
- As the First Author, it is your responsibility to provide all commercial relationship disclosures for yourself, your spouse/partner and each of your co-authors during the abstract submission process.
- Relevant nonremunerative positions that may create a conflict of interest must also be reported.
Travel Grants, ARVO/Alcon Award and MIT Outstanding Poster Award
- Apply for an ARVO Travel Grant with your Annual Meeting abstract submission.
- More than 280 grants are available for Members-In-Training.
- The ARVO/Alcon Early Career Clinician-Scientist Research Award supports researchers who are committed to careers as clinician-scientists.
- The Member-In-Training (MIT) Committee announces the MIT Outstanding Poster Award for the ARVO 2018 Annual Meeting
Abstract submission assistance
- For technical support during abstract submission, send your request to email@example.com or contact by phone at +1.434.964.4100 or toll free (US Only) at 888.503.1050, Monday 12am - Friday 5:30pm, U.S. ET.
- Policy and procedure questions should be directed to ARVO at firstname.lastname@example.org or contact by phone at +18.104.22.16800, Monday - Friday 8:30am - 5pm U.S. ET.